Corbus Pharmaceuticals Holdings, Inc. Contract Liability (Deferred Revenue)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Contract Liability (Deferred Revenue) of $2.48 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2019-08-08
- 2019-06-30: Contract with Customer, Liability, Current $2.48M.
- 2019-03-31: Contract with Customer, Liability, Current $27.00M.
- 2018-12-31: Contract with Customer, Liability, Current $1.46M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2019-06-30 | $2.48M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $27.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.46M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |